Exploring Werner Helicase Inhibitors Looking Beyond Immunotherapy For Msi Tumors
If you are looking for information about Werner Helicase Inhibitors Looking Beyond Immunotherapy For Msi Tumors, you have come to the right place.
- Kristen Ciombor, MD, MSCI, Vanderbilt-Ingram
- Heinz-Josef Lenz, MD, FACP, University of Southern California, Los Angeles, CA, discussed the introduction of
- Alan Venook, MD, Professor, Department of Medicine, UCSF Helen Diller Family Comprehensive
- Arvind Dasari, MD, MS, The University of Texas MD Anderson
- John Strickler, MD, Duke University, Durham, NC, gives an overview of the Phase III CheckMate 8HW trial (NCT04008030), which ...
In-Depth Information on Werner Helicase Inhibitors Looking Beyond Immunotherapy For Msi Tumors
Timothy Yap, MBBS, PhD, FRCP, The University of Texas MD Anderson Antonio Marra, MD, European Institute of Oncology IRCCS, Milan, Italy, gives an overview of interim results from a Phase I/Ib trial ... Timothy Yap, MBBS, PhD, FRCP, The University of Texas MD Anderson Dr Timothy Yap speaks to ecancer about a first-in-human (FIH) phase 1 trial of the oral first-in-class covalent
This seminar discusses our work that led to the identification and validation of
We hope this detailed breakdown of Werner Helicase Inhibitors Looking Beyond Immunotherapy For Msi Tumors was helpful.
